![PDF) Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus PDF) Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus](https://i1.rgstatic.net/publication/321682770_Developing_a_Standard_Set_of_Patient-Centred_Outcomes_for_Inflammatory_Bowel_Disease_-_an_International_Cross-disciplinary_Consensus/links/5e7652a04585157b9a511a12/largepreview.png)
PDF) Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus
![PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders](https://i1.rgstatic.net/publication/313331403_Third_European_Evidence-based_Consensus_on_Diagnosis_and_Management_of_Ulcerative_Colitis_Part_1_Definitions_Diagnosis_Extra-intestinal_Manifestations_Pregnancy_Cancer_Surveillance_Surgery_and_Ileo-an/links/5b0c28714585157f871ca578/largepreview.png)
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
![PDF) A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) PDF) A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)](https://i1.rgstatic.net/publication/328172940_A_propensity_score-matched_comparison_of_infliximab_and_adalimumab_in_TNF-a_inhibitors_naive_and_non-naive_patients_with_Crohn's_disease_real-life_data_from_the_Sicilian_Network_for_Inflammatory_Bowel/links/5c4f4990299bf12be3ea2343/largepreview.png)
PDF) A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)
![PDF) Recognising European Cancer Nursing (RECaN): A systematic review of trial evidence that helps to identify the roles and interventions of nurses caring for patients with cancer PDF) Recognising European Cancer Nursing (RECaN): A systematic review of trial evidence that helps to identify the roles and interventions of nurses caring for patients with cancer](https://i1.rgstatic.net/publication/313164143_Recognising_European_Cancer_Nursing_RECaN_A_systematic_review_of_trial_evidence_that_helps_to_identify_the_roles_and_interventions_of_nurses_caring_for_patients_with_cancer/links/5891bd5aaca272f9a5580e97/largepreview.png)
PDF) Recognising European Cancer Nursing (RECaN): A systematic review of trial evidence that helps to identify the roles and interventions of nurses caring for patients with cancer
![Y-ECCO on Twitter: "Winners of the Yecco abstract awards #winners #ecco17 https://t.co/vaXp54pKOk" / Twitter Y-ECCO on Twitter: "Winners of the Yecco abstract awards #winners #ecco17 https://t.co/vaXp54pKOk" / Twitter](https://pbs.twimg.com/media/C4tprL3UMAADSXy.jpg:large)